Skip to content

Checking the effect of nebulised dexmedetomidine on pulmonary blood pressure in cardiac surgeries

The effect of pre-operative dexmedetomidine nebulisation on pulmonary haemodynamics during laryngoscopy and intubation in cardiac surgery patients: A prospective randomised control trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043086
Enrollment
74
Registered
2022-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring Health Condition 2: I258- Other forms of chronic ischemic heart disease Health Condition 3: I058- Other rheumatic mitral valve diseases Health Condition 4: I078- Other rheumatic tricuspid valve diseases Health Condition 5: I081- Rheumatic disorders of both mitraland tricuspid valves Health Condition 6: I051- Rheumatic mitral insufficiency Health Condition 7: I050- Rheumatic mitral stenosis Health Condition 8: I052- Rheumatic mitral stenosis with

Interventions

Intervention1: Injection Dexmedetomidine: Nebulisation in pre-operative period @ 1mcg/kg body weight diluted to 3ml, stat, for 10 mins duration Control Intervention1: Normal saline: Nebulisation with

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1. Age 18-55 years 2. Both genders 3. Elective cardiac surgery 4. Mitral valve repair or replacement 5. Mitral stenosis, mitral regurgitation 6. Coronary artery bypass graft with mitral valve replacement

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA 1. Anticipated difficult airway. 2. Preoperative heart rate 3. Uncontrolled AF and ventricular rate 4. Second degree heart block and bundle branch blocks 5. Patients with both mitral and aortic valve disease 6. Right atrial mass or thrombus 7. Emergency surgery

Design outcomes

Primary

MeasureTime frame
Compare change in pulmonary artery systolic pressure (PASP) and mean pulmonary artery pressures (mPAP) during laryngoscopy and intubation.Timepoint: Within 2 successful intubation attempts

Secondary

MeasureTime frame
Compare change in pulmonary vascular resistance (PVR)during laryngoscopes and intubationTimepoint: every 1 minute of induction of anesthesia till 15 minutes following intubation;Compare dose of inotropes or vasopressors requiredTimepoint: every 1 minute of induction of anesthesia till 15 minutes following intubation;Compare dose of propofol and fentanyl required during intubation response to optimise blood pressureTimepoint: every 1 minute of induction of anesthesia till 15 minutes following intubation;Compare PASP and systolic blood pressure (SBP) ratio (PASP/SBP) during laryngoscopy and intubationTimepoint: every 1 minute of induction of anesthesia till 15 minutes following intubation;Compare PASP, PADP, mPAP, PVR, SBP, DBP, MAP, systemic vascular resistance, cardiac output (CO) and cardiac index (CI)Timepoint: every 1 minute of induction of anesthesia till 15 minutes following intubation

Countries

India

Contacts

Public ContactDr Ajay Kumar

All India Institute Of Medical Sciences , Rishikesh

ajaymishra0701@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026